Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
R-CVP vs R-CHOP in Indolent Lymphoma
NCT00801281Phase 3Completed
- Sponsor
- Polish Lymphoma Research Group
- Start
- Feb 2007
- Primary completion
- Jun 2017
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of doxorubicin in follicular lymphoma (FL), marginal zone lymphoma (MZL), small lymphocytic lymphoma (SLL), Lymphoplasmacytic Lymphoma (LPL), sponsored by Polish Lymphoma Research Group. Started Feb 2007; status: completed.
02
Drugs
doxorubicin
03
Conditions
follicular lymphoma (FL)marginal zone lymphoma (MZL)small lymphocytic lymphoma (SLL)Lymphoplasmacytic Lymphoma (LPL)
Beyond the preview
Go deeper on NCT00801281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00801281.